Results 141 to 150 of about 62,620 (348)

IgG4-associated sclerosing cholangitis: a diagnosis that may change the course of events (review of the literature and a clinical case)

Alʹmanah Kliničeskoj Mediciny, 2018
Immunoglobulin G4-associated sclerosing cholangitis (IgG4-SC) can mimic primary sclerosing cholangitis, cholangiocarcinoma, and pancreatic adenocarcinoma. Its proper diagnosis allows for an adequate therapy and an improvement of the outcomes. The article
E. V. Vinnitskaya, T. Yu. Khaimenova, E. S. Sbikina, R. I. Alexandrova, Yu. G. Sandler   +4 more
doaj   +1 more source

Utility of serological markers in inflammatory bowel diseases: Gadget or magic? [PDF]

, 2007
The panel of serologic markers for inflammatory bowel diseases (IBD) is rapidly expanding. Although anti-Saccharomyces cerevisiae antibodies (ASCA) and atypical perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) remain the most widely ...
Altorjay, István, Lakatos, Péter László, Norman, G. L., Papp, Mária   +3 more
core   +1 more source

Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders

Hepatology Research, EarlyView.
It is speculated that the onset of obesity‐related diseases follows the sequence of obesity → SLD → MetS‐related diseases. In this study, the contribution of SLD to each MetS‐related disease was large for T2D and hypertension and SLD contributed to the onset and new onset of the disease by the 7‐year follow‐up.
Yoshihiro Kamada, Makoto Fujii, Hitoshi Nishizawa, Shiro Fukuda, Makoto Yamada, Iichiro Shimomura, Eiji Miyoshi   +6 more
wiley   +1 more source

Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use

Gastro Hep Advances
Ketamine-induced sclerosing cholangitis has been described with chronic intranasal and intravenous use. Our case follows chronic topical use for peripheral neuropathy.
Gerond Lake-Bakaar, Benjamin Milgrom, Clark Kulig, Andrea K. Sotelo, Joselle Speirs, Alexandra Meihofer   +5 more
doaj   +1 more source

Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient [PDF]

, 2013
Autoimmune liver disease management goals are primarily slowing disease progression and symptomatic treatment. There are few options for curative medical management other than transplant for a spectrum of autoimmune liver disease that encompasses ...
Abhyankar, Anita, Bonder, Alan, Tapper, Elliot   +2 more
core   +2 more sources

Editorial: serologic antibodies in primary sclerosing cholangitis—a tell‐tale sign of compromised gut‐liver immunity? Authors' reply [PDF]

, 2020
Ewa Wunsch, Piotr Milkiewicz
openalex   +1 more source

Autoimmune Hepatitis: Histopathological Diversity and Its Clinical Implications

Hepatology Research, EarlyView.
ABSTRACT Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease characterized by diverse clinical and histological manifestations. Accurate histopathological evaluation plays a critical role in determining disease activity, guiding treatment strategies, and predicting prognosis.
Mina Komuta, Kenichi Harada
wiley   +1 more source

Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man

Autopsy and Case Reports, 2013
Primary sclerosing cholangitis, a chronic progressive cholestatic liver disease, is the most serious hepatobiliary complication of ulcerative colitis (UC).
José Cândido Caldeira Xavier Júnior, Kunie Iabuki Rabello Coelho, Ligia Yukie Sassaki, Fabio da Silva Yamashiro, Kelly Cristhian Lima Oliveira, Maria Aparecida Marchesan Rodrigues   +5 more
doaj  

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis

World Journal of Gastroenterology, 2017
AIM To characterize the gut bacterial microbiota of patients with primary sclerosing cholangitis (PSC) and ulcerative colitis (UC). METHODS Stool samples were collected and relevant clinical data obtained from 106 study participants, 43 PSC patients with
L. Bajer, M. Kverka, M. Kostovčík, P. Mačinga, J. Dvorak, Zuzana Stehlikova, J. Březina, P. Wohl, J. Spicak, P. Drastich   +9 more
semanticscholar   +1 more source

Bacterial Extracellular Vesicles in the Pathogenesis and Treatment of Liver Diseases

Journal of Gastroenterology and Hepatology, EarlyView.
Liver diseases are a major global health challenge, with current treatments inadequate. This review highlights the role of bacterial extracellular vesicles in liver inflammation, fibrosis, and metabolism. We also explore these from commensals and probiotics, their protective effects, and discuss research challenges and future therapeutic potential ...
Yakun Li, Jia Li, Robin P. F. Dullaart, Han Moshage   +3 more
wiley   +1 more source